English
简体中文
Total: £ 56.28
Published Date: 2025-01-13 | Pages: 86 | Tables: 84 | Medical Care
The global market for Oncolytic Virus Therapy was valued at US$ 9.3 million in the year 2024 and is projected to reach a revised size of US$ 43.3 million by 2031, growing at a CAGR of 24.9% during the forecast period.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Segment by Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Segment by Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Therapy Market Perspective (2020-2031)
2.2 Global Oncolytic Virus Therapy Growth Trends by Region
2.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2020-2025)
2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2026-2031)
2.3 Oncolytic Virus Therapy Market Dynamics
2.3.1 Oncolytic Virus Therapy Industry Trends
2.3.2 Oncolytic Virus Therapy Market Drivers
2.3.3 Oncolytic Virus Therapy Market Challenges
2.3.4 Oncolytic Virus Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Therapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2020-2025)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncolytic Virus Therapy Revenue
3.4 Global Oncolytic Virus Therapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2024
3.5 Global Key Players of Oncolytic Virus Therapy Head office and Area Served
3.6 Global Key Players of Oncolytic Virus Therapy, Product and Application
3.7 Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Therapy Breakdown Data by Type
4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2020-2025)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031)
5 Oncolytic Virus Therapy Breakdown Data by Application
5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2020-2025)
5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncolytic Virus Therapy Market Size (2020-2031)
6.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncolytic Virus Therapy Market Size by Country (2020-2025)
6.4 North America Oncolytic Virus Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Therapy Market Size (2020-2031)
7.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncolytic Virus Therapy Market Size by Country (2020-2025)
7.4 Europe Oncolytic Virus Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2020-2031)
8.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Therapy Market Size (2020-2031)
9.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncolytic Virus Therapy Market Size by Country (2020-2025)
9.4 Latin America Oncolytic Virus Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2020-2031)
10.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Therapy Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Details
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Details
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Therapy Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Details
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Therapy Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Details
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Details
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Therapy Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Details
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Details
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Details
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Details
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Details
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Details
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Therapy Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Details
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Details
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2020-2025)
11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of HSV-based Oncolytic Viruses
Table 3. Key Players of Adenoviruses-based Oncolytic Viruses
Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses
Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses
Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Oncolytic Virus Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Oncolytic Virus Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Oncolytic Virus Therapy Market Share by Region (2020-2025)
Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Oncolytic Virus Therapy Market Share by Region (2026-2031)
Table 13. Oncolytic Virus Therapy Market Trends
Table 14. Oncolytic Virus Therapy Market Drivers
Table 15. Oncolytic Virus Therapy Market Challenges
Table 16. Oncolytic Virus Therapy Market Restraints
Table 17. Global Oncolytic Virus Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Oncolytic Virus Therapy Market Share by Players (2020-2025)
Table 19. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2024)
Table 20. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Oncolytic Virus Therapy, Headquarters and Area Served
Table 23. Global Key Players of Oncolytic Virus Therapy, Product and Application
Table 24. Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2020-2025)
Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2026-2031)
Table 30. Global Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Application (2020-2025)
Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Oncolytic Virus Therapy Revenue Market Share by Application (2026-2031)
Table 34. North America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Oncolytic Virus Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Oncolytic Virus Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Oncolytic Virus Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Oncolytic Virus Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Oncolytic Virus Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Oncolytic Virus Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Amgen Company Details
Table 50. Amgen Business Overview
Table 51. Amgen Oncolytic Virus Therapy Product
Table 52. Amgen Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Oncolytics Biotech Company Details
Table 55. Oncolytics Biotech Business Overview
Table 56. Oncolytics Biotech Oncolytic Virus Therapy Product
Table 57. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 58. Oncolytics Biotech Recent Development
Table 59. Viralytics Company Details
Table 60. Viralytics Business Overview
Table 61. Viralytics Oncolytic Virus Therapy Product
Table 62. Viralytics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 63. Viralytics Recent Development
Table 64. Transgene SA Company Details
Table 65. Transgene SA Business Overview
Table 66. Transgene SA Oncolytic Virus Therapy Product
Table 67. Transgene SA Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 68. Transgene SA Recent Development
Table 69. Oncolys BioPharma Company Details
Table 70. Oncolys BioPharma Business Overview
Table 71. Oncolys BioPharma Oncolytic Virus Therapy Product
Table 72. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 73. Oncolys BioPharma Recent Development
Table 74. Targovax Company Details
Table 75. Targovax Business Overview
Table 76. Targovax Oncolytic Virus Therapy Product
Table 77. Targovax Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 78. Targovax Recent Development
Table 79. PsiOxus Therapeutics Company Details
Table 80. PsiOxus Therapeutics Business Overview
Table 81. PsiOxus Therapeutics Oncolytic Virus Therapy Product
Table 82. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 83. PsiOxus Therapeutics Recent Development
Table 84. SillaJen Biotherapeutics Company Details
Table 85. SillaJen Biotherapeutics Business Overview
Table 86. SillaJen Biotherapeutics Oncolytic Virus Therapy Product
Table 87. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 88. SillaJen Biotherapeutics Recent Development
Table 89. Sorrento Therapeutics Company Details
Table 90. Sorrento Therapeutics Business Overview
Table 91. Sorrento Therapeutics Oncolytic Virus Therapy Product
Table 92. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 93. Sorrento Therapeutics Recent Development
Table 94. Lokon Pharma Company Details
Table 95. Lokon Pharma Business Overview
Table 96. Lokon Pharma Oncolytic Virus Therapy Product
Table 97. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 98. Lokon Pharma Recent Development
Table 99. Genelux Corporation Company Details
Table 100. Genelux Corporation Business Overview
Table 101. Genelux Corporation Oncolytic Virus Therapy Product
Table 102. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 103. Genelux Corporation Recent Development
Table 104. Vyriad Company Details
Table 105. Vyriad Business Overview
Table 106. Vyriad Oncolytic Virus Therapy Product
Table 107. Vyriad Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 108. Vyriad Recent Development
Table 109. TILT Biotherapeutics Company Details
Table 110. TILT Biotherapeutics Business Overview
Table 111. TILT Biotherapeutics Oncolytic Virus Therapy Product
Table 112. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 113. TILT Biotherapeutics Recent Development
Table 114. Cold Genesys Company Details
Table 115. Cold Genesys Business Overview
Table 116. Cold Genesys Oncolytic Virus Therapy Product
Table 117. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)
Table 118. Cold Genesys Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Oncolytic Virus Therapy Picture
Figure 2. Global Oncolytic Virus Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncolytic Virus Therapy Market Share by Type: 2024 VS 2031
Figure 4. HSV-based Oncolytic Viruses Features
Figure 5. Adenoviruses-based Oncolytic Viruses Features
Figure 6. Vaccinia Virus-based Oncolytic Viruses Features
Figure 7. Vesicular Stomatitis Virus-based Oncolytic Viruses Features
Figure 8. Newcastle Disease Virus-based Oncolytic Viruses Features
Figure 9. Global Oncolytic Virus Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Oncolytic Virus Therapy Market Share by Application: 2024 VS 2031
Figure 11. Melanoma Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Breast Cancer Case Studies
Figure 14. Ovarian Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Oncolytic Virus Therapy Report Years Considered
Figure 17. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Oncolytic Virus Therapy Market Share by Region: 2024 VS 2031
Figure 20. Global Oncolytic Virus Therapy Market Share by Players in 2024
Figure 21. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2024
Figure 23. North America Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Oncolytic Virus Therapy Market Share by Country (2020-2031)
Figure 25. United States Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Oncolytic Virus Therapy Market Share by Country (2020-2031)
Figure 29. Germany Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Oncolytic Virus Therapy Market Share by Region (2020-2031)
Figure 37. China Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Oncolytic Virus Therapy Market Share by Country (2020-2031)
Figure 45. Mexico Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2020-2031)
Figure 49. Turkey Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 53. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 54. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 55. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 56. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 57. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 58. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 59. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 60. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 61. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 62. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 63. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 64. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 65. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
